Antimicrobial actions of the nadph phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo

Journal of Experimental Medicine

Volumn 192, Issue 2, 2000, Pages 237-247

  Mastroeni, Pietro ^a,b   Vazquez Torres, Andrés ^c   Fang, Ferric C ^c   Xu, Yisheng ^c   Khan, Shahid ^a   Hormaeche, Carlos E ^a,d   Dougan, Gordon ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF COLORADO   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Innate immunity; Nitrosative; Oxidative; Salmonella; Virulence

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; HOST RESISTANCE; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STRAIN DIFFERENCE;

ANIMALS; FLOW CYTOMETRY; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM;

EID: 0034679699     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.2.237     Document Type: Article

References (59)

1. Collins, F.M. 1974. Vaccines and cell mediated immunity. Bacteriol. Rev. 38:371-402.
2. Hormaeche, C.E., C.M.A. Khan, P. Mastroeni, B. Villarreal, G. Dougan, and S.N. Chatfield. 1994. Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens. In Molecular and Clinical Aspects of Vaccine Development. D. Ala, D. Aldeen, and C.E. Hormaeche, editors. John Wiley & Sons, Chichester, UK. 19-153.
3. Mastroeni, P., J.A. Harrison, and C.E. Hormaeche. 1994. Natural resistance and acquired immunity to Samonella. Fund. Clin. Immunol. 2:83-95.
4. Fields, P.I., R.V. Swanson, C.G. Haidaris, and F. Heffron. 1986. Mutants of Salmonella typhimurium that cannot survive within macrophages are avirulent. Proc. Natl. Acad. Sci. USA. 83:5189-5193.
5. Hoiseth, S.K., and B.A.D. Stocker. 1981. Aromatic dependent Salmonella typhimurium are non virulent and effective as live vaccines. Nature. 291:238-239.
6. Hormaeche, C.E. 1979. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology. 37: 311-318.
7. Lissner, C.R., R.N. Swanson, and A.D. O'Brien. 1983. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J. Immunol. 131:3006-3013.
8. Maskell, D.J., C.E. Hormaeche, K.E. Harrington, H.S. Joysey, and F.Y. Liew. 1987. The initial suppression of bacterial growth in a Salmonella infection is mediated by a localised rather than a systemic response. Microb. Pathog. 2:295-305.
9. Mastroeni, P., J.N. Skepper, and C.E. Hormaeche. 1995. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect. Immun. 63: 3674-3682.
10. Richter-Dahlfors, A., A.M.J. Buchan, and B. Finlay. 1997. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo J. Exp. Med. 186:569-580.
11. Hormaeche, C.E., P. Mastroeni, A. Arena, J. Uddin, and H.S. Joysey. 1990. T cells do not mediate the initial suppression of a Salmonella infection in the RES. Immunology. 70: 247-250.
12. Everest, P., M. Roberts, and G. Dougan. 1998. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor. Infect. Immun. 66:3355-3364.
13. - infection in gene targeted immunodeficient mice. J. Immunol. 156:3321-3326.
14. Kagaya, K., K. Watanabe, and Y. Fukazawa. 1989. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect. Immun. 57:609-615.
15. Kincy-Cain, T., J.D. Clements, and L. Bost. 1996. Endogenous and exogenous interleukin-12 augment protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64:1437-1440.
16. Mastroeni, P., A. Arena, G.B. Costa, M.C. Liberto, L. Bonina, and C.E. Hormaeche. 1991. Serum TNFα in mouse typhoid and enhancement of a Salmonella infection by anti-TNFα antibodies. Microb. Pathog. 11:33-38.
17. Mastroeni, P., B. Villarreal-Ramos, and C.E. Hormaeche. 1992. Role of T-cells, TNFα and IFNγ in recall of immunity to oral challenge with virulent salmonellae in mice immunised with live attenuated aroA Salmonella vaccines. Mirob. Pathog. 13:477-491.
18. Mastroeni, P., B. Villarreal-Ramos, and C.E. Hormaeche. 1993. Effect of late administration of anti-TNFα antibodies on a Salmonella infection in the mouse model. Microb. Pathog. 14:473-480.
19. Mastroeni, P., J.A. Harrison, J.A. Chabalgoity, and C.E. Hormaeche. 1995. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect. Immun. 64:189-196.
20. Mastroeni, P., J.A. Harrison, J.H. Robinson, S. Clare, S. Khan, D.J. Maskell, G. Dougan, and C.E. Hormaeche. 1998. Interleukin 12 is required for the control of the growth of attenuated aromatic-compound dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect. Immun. 66:4767-4776.
21. Mastroeni, P., S. Clare, S. Khan, J.A. Harrison, C.E. Hormaeche, H. Okamura, M. Kurimoto, and G. Dougan. 1999. IL18 (IGIF) contributes to host resistance and IFNγ production in mice infected with virulent S. typhimurium. Infect. Immun. 67:478-483.
22. Tite, J.P., G. Dougan, and S.N. Chatfield. 1991. The involvement of tumor necrosis factor in immunity to Salmonella infection. J. Immunol. 147:3161-3164.
23. Buchmeier, N., C.J. Lipps, M.H.Y. So, and F. Heffron. 1993. Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Mol. Microbiol. 7:933-936.
24. De Groote, M.A., U.A. Ochsner, M.U. Shiloh, C. Nathan, J.M. McCord, M.C. Dinauer, S.J. Libby, A. Vazquez-Torres, Y. Xu, and F. Fang. 1997. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 94:13997-14001.
25. Mouy, R., A. Fischer, E. Vilmer, R. Seger, and C. Griscelli. 1989. Incidence, severity, and prevention of infections in chronic granulomatous disease. J. Pediatr. 114:555-560.
26. Pollock, J.D., D.A. Williams, M.A.C. Gifford, L.L. Li, X. Du, J. Fisherman, S.H. Orkin, C.M. Doershuck, and M.C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209.
27. Adams, L.B., M.C. Dinauer, D.E. Morgenstern, and J.K. Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung. Dis. 78:237-246.
28. Shiloh, M.U., J. Ruan, and C. Nathan. 1997. Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay. Infect. Immun. 65:3193-3198.
29. Shiloh, M.U., J.D. MacMiking, S. Nicholson, J.E. Brause, S. Potter, M. Marino, F. Fang, M. Dinauer, and C. Nathan. 1999. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity. 10:29-38.
30. Fang, F. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99:2818-2825.
31. DeGroote, M.A., and F.C. Fang. 1999. Antimicrobial properties of nitric oxide. In Nitric Oxide and Infection. F.C. Fang, editor. Kluwer Academic/Plenum Publishers, New York. 231-261.
32. Umezawa, K., T. Akaike, S. Fujii, M. Suga, K. Setoguchi, A. Ozawa, and H. Maeda. 1997. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against S. typhimurium infection in mice. Infect. Immun. 65:2932-2940.
33. De Groote, M.A., T. Testerman, Y. Xu, G. Stauffer, and F.C. Fang. 1996. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science. 272:414-417.
34. Khan, S.A., P. Everest, S. Servos, N. Foxwell, U. Zahringer, H. Brade, E.T. Rietschel, G. Dougan, I.G. Charles, and D.J. Maskell. 1998. A lethal role for lipid A in Salmonella infections. Mol. Microbiol. 29:571-579.
35. Vazquez-Torres, A., J. Jones-Carson, P. Mastroeni, H. Ischiropoulous, and F.C. Fang. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192:227-236.
36. MacFarlane, A.S., M.G. Schwacha, and T.K. Eisenstein. 1999. In vivo blockage of nitric oxide with aminoguanidine inhibits imniunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect. Immun. 67:891-898.
37. Laubach, V.E., E.G. Shesely, O. Smithies, and P.A. Sherman. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA. 92:10688-10692.
38. Wei, X., I.G. Charles, A. Smith, J. Ure, G. Feng, F. Huang, D. Xu, W. Muller, S. Moncada, and F.Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:408-411.
39. Reed, L.J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
40. Vidal, S.M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 73:469-485.
41. Hormaeche, C.E. 1980. The in vivo division and death rates of Salmonella typhimurium in the spleens of naturally resistant and susceptible mice measured by the superinfecting phage technique of Meynell. Immunology. 41:973-979.
42. Pacelli, R., D.A. Wink, J.A. Cook, M.C. Krishna, W. DeGraff, N. Friedman, M. Tsokos, A. Samuni, and J.B. Mitchell. 1995. Nitric oxide potentiates hydrogen peroxide-induced killing of Eseherichia coli. J. Exp. Med. 182:1469-1479.
43. Wink, D.A., J.A. Cook, S.Y. Kim, Y. Vodovotz, R. Pacelli, M.C. Krishna, A. Russo, J.B. Mitchell, D. Jourd'heuil, A.M. Miles, and M.B. Grisham. 1997. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J. Biol. Chem. 272:11147-11151.
44. Tamura, M., M. Takeshita, J.T. Curnutte, D.J. Uhlinger, and J.D. Lambeth. 1992. Stabilization of human neutrophil NADPH oxidase activated in a cell-free system by cytosolic proteins and by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide. J. Biol. Chem. 267:7529-7538.
45. Iha, S., K. Orita, T. Kanno, T. Utsumi, E.F. Sato, M. Inoue, and K. Utsumi. 1996. Oxygen-dependent inhibition of neutrophil respiratory burst by nitric oxide. Free Radic. Res. 25: 489-498.
46. Vassiloyanakopoulos, A.P., S. Okamoto, and J. Fierer. 1998. The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. Proc. Natl. Acad. Sci. USA. 95:7676-7681.
47. Sinha, K.A., P. Mastroeni, J. Harrison, R.D. de Hormaeche, and C.E. Hormaeche. 1997. Salmonella typhimurium aroA, htrA and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect. Immun. 65:1566-1569.
48. Gomes, M.S., M. Florido, T.F. Pais, and R. Appelberg. 1999. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase. J. Immunol. 162:6734-6739.
49. Millar, A.E., J. Stenberg, C. McSharry, X.Q. Wei, F.Y. Liew, and C.M. Turner. 1999. T-cell responses during Trypanasoma brucei infections in mice deficient in inducible nitric oxide synthase. Infect. Immun. 67:3334-3338.
50. Everest, P., J. Allen, A. Papacostantinopoulou, P. Mastroeni, M. Roberts, and G. Dougan. 1997. Salmonella typhimurium infections in mice deficient in interleukin-4 production: role of 1L-4 in infection associated pathology. J. Immunol. 159: 1820-1827.
51. G-monomethyl-L-arginine. J. Immunol. 159:5063-5069.
52. McInnes, I.B., and F.Y. Liew. 1999. Immunomodulatory actions of nitric oxide. In. Nitric Oxide and Infection. F.C. Fang, editor. Kluwer Academic/Plenum Publishers, New York. 199-213.
53. Ehlers, S., S. Kutsch, J. Benini, A. Cooper, C. Hanhn, J. Gerdes, I. Orme, C. Martin, and E.T. Rietschel. 1999. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. J. Immunol. 98: 313-323.
54. Hickey, M.J., K.A. Sharkey, E.G. Sihota, P.H. Reinhardt, J.D. Macmicking, C. Nathan, and P. Kubes. 1997. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11: 955-964.
55. Trinchieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr. Opin. Immunol. 9:17-23.
56. Hertz, C.J., and J.M. Mansfield. 1999. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cell. Immunol. 192:24-32.
57. Wray, G., and G. Thiemermann. 1999. Nitric oxide in sepsis. In Nitric Oxide and Infection. F.C. Fang, editor. Kluwer Academic/Plenum Publishers, New York. 265-280.
58. Niedbala, W., X.Q. Wei, D. Piedrafita, D. Xu, and F.Y. Liew. 1999. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur. J. Immunol. 29:2498-2505.
59. Boockvar, K.S., D.L. Granger, R.M. Poston, M. Maybody, M.K. Washington, J.B. Hibbs, and R.L. Kurlander. 1994. Nitric oxide produced during murine listeriosis is protective. Infect. Immun. 62:1089-1100.